1 / 23

2012: Future Impact of Health Care Reform on Laboratory Business

2012: Future Impact of Health Care Reform on Laboratory Business. By: Mark S. Birenbaum, Ph.D. Administrator National Independent Laboratory Association (NILA) November 9, 2012.

freds
Download Presentation

2012: Future Impact of Health Care Reform on Laboratory Business

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. 2012: Future Impact of Health Care Reform on Laboratory Business By: Mark S. Birenbaum, Ph.D. Administrator National Independent Laboratory Association (NILA) November 9, 2012 National Independent Laboratory Association, 906 Olive Street, Suite 1200, Saint Louis, Missouri 63101-1448Telephone: 314-241-1445, Fax: 314-241-1449, Web Site: www.nila-usa.com

  2. Healthcare Reform May Be Good If You Live To Tell About It

  3. Tax Versus 1.75% Part B Cuts And Permanent Versus Temporary November 6, 2009

  4. Clinical Laboratory Fee Schedule CutEffective January 1, 2013

  5. Overall -28.45% + 9.6% = -19.25% *ACA: Affordable Care Act

  6. Impact of Cuts on Medicare Payments Test Paid at $10 in 2010 17% Cut

  7. September 15, 2011 MedPAC Public Meeting

  8. Potential Medicare offset options for repealing the SGR System TABLE A-4 BLE

  9. September 27, 2011 Meeting with MedPAC Attending: NILA Mark Birenbaum, Ph.D. Julie Allen Erin Will Morton ACLA Alan Mertz Roche Diagnostics Kathleen Claessens MedPAC Mark Miller, Ph.D., Executive Director James Mathews, Ph.D., Deputy Director Ariel Winter, MPP, Principal Policy Analyst

  10. George Washington University (GWU) SurveySpring-Fall 2012Commissioned by the National Independent Laboratory Association

  11. List of Independent Community Labs for the GWU Survey lBegan with the June 14, 2012, CLIA List of Independent Laboratories in all 50 States (approximately 4,000 laboratories). lExcluded:  Laboratories affiliated with other practice structures (i.e., physician office laboratories or hospitals) or other laboratories that did not meet the definition of an independent laboratory.  Publicly traded national laboratories (e.g., LabCorp, Quest).  Hospital laboratories without a separate federal tax ID number (Medicare reimbursement for hospital laboratories is mainly derived from Medicare Part A).  Assisted Reproductive Laboratories/In Vitro Fertilization Laboratories. (These laboratories receive little or no Medicare reimbursement). l Subsequently generated a convenience sample of approximately 180 laboratories. l 77 laboratories from 22 states completed the survey.

  12. Market Analysis • Profit margin • Impact of Medicare cuts • Payer mix • Beneficiary mix • Case studies • Most pressing business concerns

  13. Services by Customer Type Practice Hospitals NH/SNFs ALFs Home CHCs

  14. Average Profit Margin 0-3% 4-6% 7-9% 10-12% 12-15% >15%

  15. Key Findings: Profit Margin • Laboratories with low profit margins were more likely to: • Serve rural communities: Nearly 40 percent of laboratories serving rural communities had low profit margins. • Provide most of their stat and same-day turnaround testing to nursing homes/SNFs: 71 percent of labs that provide the majority of their stat and same-day turnaround testing to nursing homes and SNFs had low profit margins.

  16. Anticipated Business Challenges Medicare cuts Nat’l Insurers HIT Regs ACO Medicaid cuts Medicare changes Other Mergers Contract

  17. 2013 Regulatory ActivityAffecting Laboratory Business • Direct access to lab test results – waiting on release of a final rule • Molecular test placement and payment – November 2012 CMS decision to place tests on Part B CLFS instead of PFS • Laboratory developed tests – regulatory authority to be FDA or CLIA? • Health reform – future of state exchanges (laboratory services a required benefit to be provided through the exchange); development of ACOs and other payment reform models

  18. NILA’s 2013 Legislative and Regulatory Activity • Meet with MedPAC to Present Results of GWU Survey • Partner with Other Lab Associations Through Clinical Laboratory Coalition (CLC) • Encourage Members of Congress and Hill Staffers to Visit NILA Members’ Laboratories • Take Message to Capitol Hill During “Lame Duck” Session

  19. NILA Capitol Hill DayNovember 14-15, 2012Liaison Hotel l Washington, DC

  20. NILA ALERT!!! In 2013 Watch Out For More Part B CLFS Cuts Resurrection of Competitive Bidding Proposals Resurrection of Copay/Coinsurance Proposals

  21. Challenges Ahead Migration of Independent Physician Practices to Hospitals Restrictive Policies of National Insurance Companies Costs and Difficulties of Adopting and Connecting to Electronic Health Information Systems Decreases in Lab Testing Volumes Due To Poor Economy Changes in Ordering Patterns Frequency Limitations

More Related